Paeds Cases · fetal-neonatal-and-perinatal
Neonatal cyanosis and collapsed neonate — structured clinical encounter
Structured encounter testing the approach to a day-3 term infant with sudden central cyanosis: recognition, the pre-/post-ductal and hyperoxia assessment, the time-critical use of prostaglandin E1 before echo, and the parallel sepsis cover.
On this page & tools
Target exams
Station brief (candidate)
You are the paediatric registrar in the emergency department. A 3-day-old term infant, previously feeding well and discharged home, is brought in dusky and limp. The tongue and lips are blue. The respiratory rate is 60 with mild recession; there is no murmur. The right-arm oxygen saturation is 82%. The antenatal scans and the newborn pulse-oximetry screen were reportedly normal. You have 12 minutes with the team and 5 minutes for examiner discussion. [3]
Information available on request
- Term infant, day 3 of life, previously well and feeding normally; sudden onset of duskiness over the last few hours. [3]
- Central cyanosis: blue tongue and lips; respiratory rate 60 with mild recession; no murmur; right-arm SpO2 82%. [3]
- Antenatal scans and newborn pulse-oximetry screen reported as normal; no family history of congenital heart disease. [3]
- No maternal group B streptococcus risk factors identified; no perinatal asphyxia. [8]
Tasks
- Confirm whether this is central or peripheral cyanosis and state the most likely diagnostic category, justifying your call. [3]
- Describe your immediate management, including the time-critical drug, its dose, route and the timing of administration relative to echocardiography. [3] [6]
- Describe the first-hour investigation bundle and how you would use the pre-/post-ductal difference and the hyperoxia test to decide whether the heart is the problem. [3]
- State the sepsis consideration and the disposition plan, including retrieval on prostaglandin. [8] [9]
Marking anchors
Must-hit
- Confirms central cyanosis (blue tongue and lips) and identifies a duct-dependent cardiac lesion as the most likely cause: a day-2-to-7 collapse in a previously well term infant with cyanosis and little respiratory distress is the classic duct-dependent signature, and a passed pulse-oximetry screen does not exclude critical congenital heart disease. [3]
- Starts prostaglandin E1 (alprostadil) NOW — 0.01 to 0.05 mcg/kg/min IV continuous, titrating to 0.1 to 0.4 mcg/kg/min to the lowest effective dose — BEFORE the echocardiogram, because re-opening the ductus is life-saving and the risk of an unnecessary infusion is far lower than the risk of a closed duct. Stabilises with ABCDE, oxygen to target saturations, glucose and temperature, and IV access. [3] [6]
- Orders the first-hour bundle: simultaneous pre-/post-ductal oximetry, blood gas with glucose/lactate, FBC/CRP, blood cultures, chest X-ray, four-limb BP; performs the hyperoxia test if stable enough, interpreting the 150 mmHg (rises — not CHD) and 100 mmHg (stays low — cyanotic CHD) cut-points. [3]
Merit
- Gives empiric antibiotics (benzylpenicillin plus an aminoglycoside such as gentamicin) after cultures, because the cyanotic neonate is septic until proven otherwise; uses the neonatal early-onset sepsis risk calculator to frame the risk but treats the sick infant regardless. [8] [9]
- Plans disposition: urgent echocardiography and cardiology, tertiary/cardiac NICU or PICU, continuing prostaglandin at the lowest effective dose, and coordinated retrieval — intubating selectively for prostaglandin-induced apnoea or ventilation failure rather than as routine. [6]
- Anticipates the side-effects of prostaglandin (apnoea — intubate, do not stop the drug; hypotension; fever; gastrointestinal effects rising with cumulative dose) and the principle of the lowest effective dose pending definitive repair. [6]
Fail
- Waits for the echocardiogram before starting prostaglandin, during which the duct closes further and the infant deteriorates. [3]
- Dismisses the cyanosis as benign acrocyanosis (the tongue was not checked) and delays investigation. [3]
- Omits sepsis cover while chasing the heart, or fails to escalate to retrieval and cardiology. [8]
References
- [1]Wyckoff MH; Wyllie J; Aziz K; de Almeida MF; et al Neonatal Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation, 2020.PMID 33084392
- [3]Strobel AM; Lu le N The Critically Ill Infant with Congenital Heart Disease. Emerg Med Clin North Am, 2015.PMID 26226862
- [6]Browning Carmo KA; Barr P; West M; Nicholl M; et al Transporting newborn infants with suspected duct dependent congenital heart disease on low-dose prostaglandin E1 without routine mechanical ventilation. Arch Dis Child Fetal Neonatal Ed, 2007.PMID 16905574
- [8]Davis AL; Carcillo JA; Aneja RK; Deymann AJ; et al American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock. Crit Care Med, 2017.PMID 28509730
- [9]Kuzniewicz MW; Puopolo KM; Fischer A; Walsh EM; et al A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis. JAMA Pediatr, 2017.PMID 28241253